PLATINUM NMN 150/300MG

PLATINUM NMN 150mg / 300mg

PLATINUM NMN is presented in the supplied product materials as freeze-dried beta-nicotinamide mononucleotide (NMN), with 150mg and 300mg specifications. The supplied images show vial packaging, an outer carton, Japanese-origin statements and the name 明治製薬研究所.

This description separates supplied packaging statements, publicly available institutional information and general research background. It does not establish approval, clinical efficacy or injectable suitability for this finished product.

Product Identification

• Product name: PLATINUM NMN
• Displayed specifications: 150mg / 300mg
• Declared ingredient: beta-nicotinamide mononucleotide (NMN)
• Displayed formulation: freeze-dried powder
• Presentation shown: vials and an outer carton
• Origin statement: Japan / 日本製, according to supplied materials
• Institutional name displayed: 明治製薬研究所

Institutional Background

The website of 明治製薬研究所 identifies the institute as 明治製薬研究所LLP, based in Shinagawa, Tokyo. Its development information includes NMN supplements and freeze-dried products.

This institutional background does not independently identify the legal manufacturer of the supplied PLATINUM NMN batch, confirm a manufacturing site or establish product authorization.

Ingredient and Formulation

The supplied packaging identifies beta-nicotinamide mononucleotide as the declared ingredient. The complete quantitative formulation, excipients and strength-specific specifications remain unconfirmed.

The product name should not be used to infer the presence of platinum metal, NAD+, placenta, exosomes or other additional ingredients.

150mg and 300mg Specifications

The supplied text describes 150mg and 300mg per-bottle options, and the images display both specifications. The actual strength of each supplied item must be checked against its vial label, carton and batch documentation.

These quantities are stated product specifications. They are not administration recommendations and do not establish a concentration in mg/mL.

Purity Statements

The visible carton states “purity: >99.9% (HPLC),” while a promotional image separately states 99.99%. These statements have not been reconciled through an original analytical report.

Batch-specific purity, the tested material and the applicable analytical specification remain unconfirmed. No claim of verified pharmaceutical-grade or injectable-grade quality is made in this listing.

General Research Context — Not Product-Specific Evidence

A 2022 exploratory human study examined a single intravenous NMN administration in 10 healthy volunteers, with short-term monitoring and blood NAD+ measurements. The corresponding trial registration describes an open-label, non-randomized, uncontrolled design.

These findings do not validate PLATINUM NMN, establish a routine dose, demonstrate long-term safety or substantiate age reversal or disease-treatment claims.

Promotional Positioning

The supplied materials discuss cellular energy, healthy aging, skin appearance, immune function, cognitive health and other wellness-related themes. These are promotional themes, not confirmed clinical benefits of this finished product.

This listing does not endorse claims of 100% bioavailability, age reversal, disease prevention, disease treatment or predictable benefits lasting for a specified period.

Administration Information

The supplied text describes intended intravenous administration. Official instructions, regulatory status and documentation supporting sterile injectable use remain unconfirmed. The product is not reclassified here as an oral supplement or topical cosmetic.

No administration dose, diluent, reconstitution procedure, infusion rate or treatment schedule is provided. Do not self-administer.

Storage

The supplied information states room-temperature storage. An official temperature range, shelf life, light and moisture precautions, and post-reconstitution storage conditions remain unconfirmed.

Quality Documentation Requiring Confirmation

• Legal manufacturer and manufacturing-site address
• Complete formulation and excipient list
• Labels and specifications for each strength
• Number of vials per carton
• Batch-specific certificate of analysis and HPLC report
• Applicable manufacturing and GMP documentation
• Documentation supporting sterile injectable use
• Official instructions and regulatory status
• Storage conditions, shelf life and expiry date

Important Notice

This page is for product identification and information only. Any proposed clinical use requires verification of the actual product and batch documentation, together with assessment by an appropriately qualified healthcare professional.